Anteris Technologies Global Corp. (ASX:AVR)
6.75
+0.42 (6.64%)
Dec 4, 2025, 4:10 PM AEST
ASX:AVR Market Cap
ASX:AVR has a market cap or net worth of 278.08 million as of December 4, 2025. Its market cap has increased by 31.54% in one year.
Market Cap
278.08M
Enterprise Value
267.34M
Revenue
3.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
Market Cap Chart
Since June 27, 2011, ASX:AVR's market cap has increased from 985.19K to 278.08M, an increase of 28,126.45%. That is a compound annual growth rate of 47.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 260.78M | -12.26% |
| Dec 31, 2024 | 297.22M | -12.90% |
| Dec 29, 2023 | 341.26M | 10.57% |
| Dec 30, 2022 | 308.62M | 114.65% |
| Dec 31, 2021 | 143.78M | 548.70% |
| Dec 22, 2020 | 22.16M | -62.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.01B |
| Pro Medicus | 26.57B |
| Cochlear | 17.94B |
| Sonic Healthcare | 11.43B |
| Ramsay Health Care | 8.59B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.84B |
| Mesoblast | 3.23B |